Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 49
  • Journal CiteScore: 11.20
  • Journal Impact Factor: 8.24
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Development and Validation of RP-HPLC method for quantification of Valsartan and its Pharmaceutical Formulations

Nagakanyaka devi paladugu*, G. Devala Rao, Bonthu Satyanarayana, Deepthi Poloju

A simple, rapid, sensitive, reverse phase isocratic RP-HPLC method was developed for determination of Valsartan and its pharmaceutical formulation. The method was carried out using C18 column [Agilent ODS UG 5 column, 250mm x 4.5mm] with mobile phase comprised of Acetonitrile: Phosphate buffer (70:30 v/v) with 1.0 ml / min flow rate was quite robust. The optimum wavelength for detection was 273 nm at which better detector response for the drug was obtained. The run time was set at 7 min and the retention time was 3.5 minutes. The method was validated for specificity, accuracy, precision, linearity, limit of detection, limit of quantification, robustness, solubility and stability. LOD and LOQ were found to be 1.83 μg/ml, 5.5 μg/ml respectively. The calibration curve was linear in the concentration range of 10-50 μg/ml with coefficient of correlation 0.9993. The percentage recovery for the valsartan was found to be 99.0-100.2 and the % RSD was found to be less than 2 %. The proposed method was successfully applied for quantitative determination of valsartan in tablet dosage forms.